Gene Expression Meta-Analysis of Potential Shared and Unique Pathways between Autoimmune Diseases under Anti-TNFα

Charalabos Antonatos1, Mariza Panoutsopoulou1, Georgios K Georgakilas1,2

  • 1Laboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504 Patras, Greece.

Genes
|May 28, 2022
PubMed

Insights

Anti-tumor necrosis factor (TNFα) therapy shows varied responses in autoimmune diseases like psoriasis (PsO), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA). This meta-analysis reveals distinct gene expression patterns and common anti-inflammatory pathways, including IL-10 signaling, in response to anti-TNFα treatment.

Area of Science:

  • Immunology
  • Genomics
  • Computational Biology

Background:

  • Anti-tumor necrosis factor alpha (anti-TNFα) therapy is a cornerstone treatment for autoimmune diseases.
  • Patient responses to anti-TNFα therapy are highly variable, necessitating a deeper understanding of underlying mechanisms.
  • Psoriasis (PsO), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA) are key autoimmune conditions where anti-TNFα efficacy is observed but patient heterogeneity exists.

Purpose of the Study:

  • To conduct a meta-analysis of gene expression data from patients with PsO, IBD, and RA treated with anti-TNFα therapy.
  • To identify differentially expressed genes (DEGs) and enriched pathways associated with treatment response across these diseases.
  • To explore common and disease-specific molecular mechanisms influenced by anti-TNFα therapy.

Main Methods:

  • Meta-analysis of publicly available gene expression cDNA microarray datasets for IBD, PsO, and RA.
  • Restricted maximum likelihood method for five disease-specific and one combined random-effects meta-analyses.
  • Gene Ontology and Reactome Pathway enrichment analyses, and STRING database for gene interaction analysis.

Main Results:

  • Identified distinct pro-inflammatory DEGs that were down-regulated in each disease-specific meta-analysis.
  • Pathway analyses revealed common inflammatory patterns contributing to the pathogenesis of IBD, PsO, and RA.
  • Combined meta-analyses highlighted DEGs involved in anti-inflammatory pathways, particularly Interleukin-10 (IL-10) signaling.

Conclusions:

  • This study provides a transcriptomic framework for understanding anti-TNFα therapy response in IBD, PsO, and RA.
  • The findings suggest that IL-10 signaling plays a crucial role in the anti-inflammatory effects of anti-TNFα therapy.
  • Further elucidation of these complex molecular interactions could identify novel therapeutic targets for these autoimmune diseases.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.4K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
688
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K